GRI Bio
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has GRI Bio's balance sheet done over the years? Its assets were worth $2,956,000 last year, which is more than in the previous period. 91% of GRI Bio’s total assets is currently financed by debt. Its liabilities reached the amount of $2,697,000, which means an increase by 34% compared compared to last year.

Debt to Assets

GRI Bio, Inc. (NASDAQ:GRI): Debt to assets
2019 4275656 1.06M 24.83%
2020 955000 2.40M 252.25%
2021 218000 4.94M 2266.97%
2022 383000 2.00M 524.28%
2023 2956000 2.69M 91.24%

GRI Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
1.80M9K90K109K3.82M
Short term investments
003.80M00
Net receivables
00000
Inventory
00000
Other current assets
1.12M299K6K565K100.86K
Total current assets
2.93M308K96K674K3.92M
Non-current assets:
Property, Plant and Equipment
22K71K117K281K353.90K
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
04K5K-1-1
Total non-current assets
22K75K122K280.99K353.90K
Total assets
2.95M383K218K955K4.27M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
05K62K81K0
Short term debt
14K659K3.54M152K85.66K
Total current liabilities
2.69M1.99M4.87M2.22M807.49K
Non-current liabilities:
Long term debt
014K67K14K0
Deferred tax
00000
Other non-current liabilities
000169.99K0
Total non-current liabilities
014K67K183.99K254.35K
Total liabilities
2.69M2.00M4.94M2.40M1.06M